Parathyroid Carcinoma is a rare cause of primary hyperparathyroidism. Pre-operative diagnosis remains a challenge. Here we report a case referred to us for suspicious goiter with hypercalcemia. Cytological findings suggested it to a possible thyroid mass rather than parathyroid neoplasm. Serum parathormone level was high and the patient underwent surgery. Histopathology confirmed the diagnosis of parathyroid carcinoma. A diagnostic approach to parathyroid neoplasm, combining multimodality imaging and clinico-pathologic features, is discussed.
INTRODUCTION
Parathyroid carcinoma is a rare endocrine malignancy which usually accounts for less than 1% of all cases of hyperparathyroidism (1) . The 45-55year age group is the most affected with a slight predominance of cases in women (2) . The sign and symptoms of parathyroid carcinoma are bone pain, osteoporosis, renal stones, abdominal pain and weight loss. Physical examination may reveal a cervical mass and the biochemical abnormalities are elevated serum calcium and parathormone levels. Here we report an interesting case of parathyroid carcinoma because of its rarity as well as possible cytological and histological diagnostic dilemmas. USG is a good tool to localize parathyroid tumor. But in our patient USG neck showed large complex mass in right thyroid bed and its origin, whether thyroid or parathyroid, could not be ascertained.
CASE REPORT
Cytologically, often it is impossible to differentiate between thyroid and parathyroid tumor because there is significant overlapping in the cytomorphologic features of cells derived from parathyroid and thyroid gland (5) . Although FNAC report of our patient gave false negative result but parathyroid neoplasm should be kept in mind as differential diagnosis in case of palpable neck mass with hyperparathyroidism. Tc-99m-MIBI parathyroid scintigraphy is extremely useful in preoperative localization of parathyroid neoplasm (sensitivity 89% -98%), although it is less reliable in distinguishing adenoma from carcinoma (6, 7) . Mitochondrial uptake of sestamibi in abnormal parathyroid tissue is the primary mechanism underpinning lesion localization (8) . The nodular mass in our case showed sestamibi uptake, confined to the solid components of the tumor with no uptake in the central cystic part. Delayed imaging showed significant washout of tracer which was more consistent with thyroid origin of the mass because parathyroid lesion usually shows retention of tracer.
As cystic parathyroid lesions are a recognized cause of false negative sestamibi imaging (9), it made a diagnostic dilemma in our case in spite of its high sensitivity to diagnose parathyroid neoplasm.
Ultimate gold standard is histopathology which revealed that it was a case of parathyroid carcinoma and solved all the dilemmas.
CONCLUSION
Parathyroid carcinoma, although rare, must be considered in the differential diagnoses of a nodular thyroid mass. They are often under diagnosed preoperatively, resulting in diagnostic dilemma.
